Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jabs

Showing results (41-50 of 367) with videos related to

Pageof 37
Sort By:
JAMA Ophthalmology|June 15, 2013
The standardization of uveitis nomenclature project: the future is hereAnnabelle A Okada, Douglas A Jabs
American Journal of Ophthalmology|April 5, 2002
Fomivirsen for the treatment of cytomegalovirus retinitisDouglas A Jabs, Paul D Griffiths
American Journal of Ophthalmology|January 28, 2010
HLA typing in uveitis: use and misuseKatherine J Zamecki, Douglas A Jabs
Rheumatic Diseases Clinics of North America|November 29, 2001
Ocular manifestations of vasculitisJ E Thorne, D A Jabs
Herpes : the Journal of the IHMF|March 29, 2008
Cytomegalovirus retinitis in the era of highly active antiretroviral therapySanjay R Kedhar, Douglas A Jabs
Investigative Ophthalmology & Visual Science|September 1, 1991
Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibodyD A Jabs, R A Prendergast
Ocular Immunology and Inflammation|July 26, 2012
Treatment of CMV retinopathy in patients with AIDSM L Tay-Kearney, D A Jabs
Journal of Molecular Biology|February 5, 1999
Non-proline cis peptide bonds in proteinsA Jabs, M S Weiss, R Hilgenfeld
Nature Structural Biology|August 12, 1998
Peptide bonds revisitedM S Weiss, A Jabs, R Hilgenfeld
The Medical Clinics of North America|November 1, 1996
Ophthalmic complications of HIV infectionM L Tay-Kearney, D A Jabs
Pageof 37

Showing results (41-50 of 367) with videos related to

Sort By:
Pageof 37
JAMA Ophthalmology|June 15, 2013
The standardization of uveitis nomenclature project: the future is hereAnnabelle A Okada, Douglas A Jabs
American Journal of Ophthalmology|April 5, 2002
Fomivirsen for the treatment of cytomegalovirus retinitisDouglas A Jabs, Paul D Griffiths
American Journal of Ophthalmology|January 28, 2010
HLA typing in uveitis: use and misuseKatherine J Zamecki, Douglas A Jabs
Rheumatic Diseases Clinics of North America|November 29, 2001
Ocular manifestations of vasculitisJ E Thorne, D A Jabs
Herpes : the Journal of the IHMF|March 29, 2008
Cytomegalovirus retinitis in the era of highly active antiretroviral therapySanjay R Kedhar, Douglas A Jabs
Investigative Ophthalmology & Visual Science|September 1, 1991
Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibodyD A Jabs, R A Prendergast
Ocular Immunology and Inflammation|July 26, 2012
Treatment of CMV retinopathy in patients with AIDSM L Tay-Kearney, D A Jabs
Journal of Molecular Biology|February 5, 1999
Non-proline cis peptide bonds in proteinsA Jabs, M S Weiss, R Hilgenfeld
Nature Structural Biology|August 12, 1998
Peptide bonds revisitedM S Weiss, A Jabs, R Hilgenfeld
The Medical Clinics of North America|November 1, 1996
Ophthalmic complications of HIV infectionM L Tay-Kearney, D A Jabs
Pageof 37